NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3033% below fair value
$10.73−0.41 (-3.68%)
Close on Nov 18, 2026Market cap $1.25BP/E –Yield –
NovoCure net income
Net income is the profit left for shareholders after every expense, interest and tax.
NovoCure's net income for the twelve months ending Sep 30, 2026 was -$121.73M. For fiscal 2025 it was -$136.23M. The highest annual figure on record is $19.81M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$136.23M | – |
| FY2024 | Dec 31, 2024 | -$168.63M | – |
| FY2023 | Dec 31, 2023 | -$207.04M | – |
| FY2022 | Dec 31, 2022 | -$92.53M | – |
| FY2021 | Dec 31, 2021 | -$58.35M | -394.6% |
| FY2020 | Dec 31, 2020 | $19.81M | – |
| FY2019 | Dec 31, 2019 | -$7.23M | – |
| FY2018 | Dec 31, 2018 | -$63.56M | – |
| FY2017 | Dec 31, 2017 | -$61.66M | – |
| FY2016 | Dec 31, 2016 | -$131.85M | – |
| FY2015 | Dec 31, 2015 | -$111.58M | – |
| FY2014 | Dec 31, 2014 | -$80.68M | – |
| FY2013 | Dec 31, 2013 | -$77.37M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$10.44M | – |
| Q2 FY2026 | Jun 30, 2026 | -$15.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$71.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$24.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$37.27M | – |
| Q2 FY2025 | Jun 30, 2025 | -$40.14M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.32M | – |
| Q4 FY2024 | Dec 31, 2024 | -$65.92M | – |
| Q3 FY2024 | Sep 30, 2024 | -$30.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$33.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$38.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$47.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$49.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$57.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$53.06M | – |
| Q4 FY2022 | Dec 31, 2022 | -$37.30M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.65M | – |
| Q4 FY2021 | Dec 31, 2021 | -$26.46M | -638.1% |
| Q3 FY2021 | Sep 30, 2021 | -$13.12M | -241.4% |
| Q2 FY2021 | Jun 30, 2021 | -$14.64M | -984.7% |
| Q1 FY2021 | Mar 31, 2021 | -$4.13M | -204.5% |
| Q4 FY2020 | Dec 31, 2020 | $4.92M | +15.4% |
| Q3 FY2020 | Sep 30, 2020 | $9.28M | +381.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.66M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.95M | – |
| Q4 FY2019 | Dec 31, 2019 | $4.26M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.93M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.27M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.63M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.69M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.51M | – |
| Q1 FY2018 | Mar 31, 2018 | -$20.72M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.95M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.50M | – |
| Q2 FY2017 | Jun 30, 2017 | -$21.17M | – |
| Q1 FY2017 | Mar 31, 2017 | -$18.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$22.17M | – |
See a number that looks wrong?